{
  "ticker": "JNJ",
  "target_date": "2025-02-12",
  "actual_date": "2025-02-12",
  "collected_at": "2025-12-08T11:23:45.690226",
  "price": {
    "open": 150.66,
    "high": 151.04,
    "low": 149.69,
    "close": 150.64854431152344,
    "volume": 7746000,
    "change_1d_pct": -0.56,
    "change_7d_pct": 2.23,
    "change_30d_pct": 7.04
  },
  "technicals": {
    "rsi_14": 71.0,
    "sma_20": 146.44,
    "sma_50": 143.85,
    "macd": 2.162,
    "macd_signal": 1.706,
    "macd_histogram": 0.456,
    "bb_upper": 153.26,
    "bb_lower": 139.61,
    "price_vs_sma20_pct": 2.88,
    "price_vs_sma50_pct": 4.73,
    "volume_ratio": 0.83
  },
  "fundamentals": {
    "market_cap": 488833941504,
    "pe_ratio": 19.584461,
    "forward_pe": 19.141037,
    "price_to_book": 6.158224,
    "price_to_sales": 5.304821,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.37,
    "pct_from_52w_low": 44.22
  },
  "macro": {
    "spy": {
      "price": 598.12,
      "change_1d_pct": -0.32,
      "change_7d_pct": 0.26
    },
    "vix": {
      "level": 15.89,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.64
    },
    "dollar_index": {
      "level": 107.94
    },
    "gold": {
      "price": 2909.0
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Tweedy Browne Portfolio - Q4 2024 Update",
      "source": "SeekingAlpha",
      "datetime": 1739398529,
      "summary": "Tweedy Browne\u00e2\u0080\u0099s 13F portfolio value decreased from $2.10B to $1.48B. Click here to read more about the trades and holdings of the portfolio.",
      "url": "https://finnhub.io/api/news?id=36841fc1a25c10cbffaaa7adcc03b8e81975493129d249f1926d024e62faea3a"
    },
    {
      "headline": "Janus Henderson Global Life Sciences Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739392800,
      "summary": "The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=10b10afe2a805029d7ce2f9c8b1ec10ce14300270ce9d50ee7971586c5474449"
    },
    {
      "headline": "IGA: Good Diversification And Fully-Covered Distribution (Rating Upgrade)",
      "source": "SeekingAlpha",
      "datetime": 1739377566,
      "summary": "Voya Global Advantage and Premium Opportunity Fund has a 10.74% yield, diversification benefits, and well-covered distributions. Click for my IGA CEF update.",
      "url": "https://finnhub.io/api/news?id=2ba8d05d868d19834abb8a5b6fdaa46772c05175fc15d368f4cc2a0552dcd71b"
    },
    {
      "headline": "Invesco Growth And Income Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739310600,
      "summary": "Stock selection in the financials, consumer discretionary, communication services and information technology sectors drove the fund\u00e2\u0080\u0099s relative outperformance.",
      "url": "https://finnhub.io/api/news?id=8ab6f38c857544822579e50a6e55e360bfe73cc9c7ff547590a185c945d4eee6"
    },
    {
      "headline": "Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade",
      "source": "SeekingAlpha",
      "datetime": 1739294443,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9cdfa2dfbf0baebead37b72699c6f1fc1c9670c0fc85c53f93b32e47a1856261"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403530.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000035/xslF345X05/wk-form4_1739403530.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403421.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000033/xslF345X05/wk-form4_1739403421.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000031/xslF345X05/wk-form4_1739403336.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403114.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000029/xslF345X05/wk-form4_1739403114.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739402472.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000027/xslF345X05/wk-form4_1739402472.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}